American Journal of Clinical Nutrition, Vol 46, 840-843, Copyright © 1987 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Screening test for iron overload

BS Skikne and JD Cook
Department of Medicine, University of Kansas Medical Center, Kansas City 66103.

It is presently estimated that 2-3/10(3) people living in the United States are homozygous for the iron-loading gene and are thereby susceptible to severe iron overload. The complications of this disorder can be prevented if recognized in the asymptomatic precirrhotic stage. We have developed a simple, inexpensive screening method for its early laboratory detection based on the fact that one of the earliest laboratory manifestations of hemochromatosis is a reduction in unsaturated iron-binding capacity. The sequential addition of a small measured quantity of saturating iron and bathophenanthroline disulfonate will result in color with highly saturated but not with normal sera. This screening test almost completely differentiated between 40 normal individuals and 40 patients with iron overload (as defined by a transferrin saturation greater than 55%). The test provides a cost-effective method for screening large segments of the population to detect this genetic disorder.

This article has been cited by other articles:

				P E Hickman, L F Hourigan, L W Powell, F Cordingley, G Dimeski, B Ormiston, J Shaw, W Ferguson, M Johnson, J Ascough, et al. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis Gut, March 1, 2000; 46(3): 405 - 409. [Abstract] [Full Text] [PDF]

				S. F. Wetterhall, M. E. Cogswell, and K. V. Kowdley Public Health Surveillance for Hereditary Hemochromatosis Ann Intern Med, December 1, 1998; 129(11_Part_2): 980 - 986. [Abstract] [Full Text]

				D. L. Witte Mild liver enzyme abnormalities: eliminating hemochromatosis as cause Clin. Chem., August 1, 1997; 43(8): 1535 - 1538. [Abstract] [Full Text] [PDF]